サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1564006

小動物イメージング（生体内）の世界市場

Small Animal Imaging (In-Vivo)

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
小動物イメージング（生体内）の世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

小動物イメージング（生体内）の世界市場は2030年までに48億米ドルに到達

2023年に29億米ドルと推定される小動物イメージング（生体内）の世界市場は、分析期間2023-2030年にCAGR 7.7%で成長し、2030年には48億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるマイクロ磁気共鳴イメージングでは、CAGRが8.9％を記録し、分析期間終了までに11億米ドルに達すると予測されています。オプティカルイメージング分野の成長率は、分析期間中CAGR 7.2％と推定されます。

米国市場は7億9,370万米ドルと推定、中国はCAGR7.0％で成長予測

米国の小動物イメージング（生体内）市場は、2023年に7億9,370万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR7.0％を追いかけ、2030年までに7億3,520万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.3%と6.2%と予測されています。欧州では、ドイツがCAGR約6.1%で成長すると予測されています。

世界の小動物イメージング（生体内）市場- 主要動向と促進要因のまとめ

なぜ前臨床試験に小動物イメージングが不可欠なのか？

小動物イメージング（生体内）は、生きた動物の生物学的プロセスをモニタリングするための非侵襲的で高解像度のイメージングソリューションを提供するため、前臨床試験にとって極めて重要です。この技術は、病気の進行、治療効果、薬物動態を評価するために、医薬品開発、がん研究、循環器研究、神経科学で広く使用されています。磁気共鳴画像法（MRI）、陽電子放出断層撮影法（PET）、単一光子放出コンピュータ断層撮影法（SPECT）、コンピュータ断層撮影法（CT）などの小動物イメージング技術は、リアルタイム、縦断的、定量的データを提供し、前臨床研究の信頼性とトランスレーショナルバリューを高める。個別化医療、標的治療、分子イメージングへの注目の高まりは、研究機関、製薬会社、アカデミックラボにおける小動物イメージングシステムの採用を促進しています。

技術の進歩は小動物イメージングをどのように強化しているか？

技術の進歩は、生物学的プロセスに対する包括的な洞察を提供するマルチモーダル、ハイブリッド、AI駆動のイメージングシステムを統合することで、小動物のイメージングを強化しています。MRI、PET、SPECT、CTを組み合わせたマルチモーダルイメージングシステムの研究開発により、研究者は複数のデータポイントを同時に取得できるようになり、前臨床研究の精度と深度が向上しています。AIベースの画像解析、深層学習アルゴリズム、データ管理システムの革新により、画像データの自動化、高スループット化、定量的解析が容易になり、前臨床ワークフローの時間と複雑さが軽減されています。さらに、ポータブルでコンパクトな使いやすいイメージングシステムの出現により、中小規模の研究室でも高度なイメージング技術へのアクセスが拡大し、共同研究や知識の共有が強化されています。

小動物イメージングをリードする市場セグメンテーションは？

イメージングモダリティには、マイクロMRI、PET、SPECT、CT、光イメージング（生物発光と蛍光）、超音波が含まれ、光イメージングとPETは、その高い感度、特異性、リアルタイムイメージング機能により市場をリードしています。使用事例は、腫瘍学、神経学、循環器学、感染症学、免疫学などであり、中でも腫瘍学は、がん研究や医薬品開発研究が盛んであることから、最大の分野となっています。エンドユーザーには、学術・研究機関、製薬・バイオテクノロジー企業、CRO（医薬品開発業務受託機関）などが含まれ、学術・研究機関は基礎研究やトランスレーショナル研究に重点を置いているため、1次調査機関となっています。地理的には、北米と欧州が、高度な研究インフラを背景に小動物用イメージングの最大市場である一方、アジア太平洋は、ライフサイエンスへの投資の増加、研究開発活動の拡大、精密医療への注目の高まりを背景に、高成長地域として浮上しています。

小動物イメージング市場の成長促進要因は？

小動物イメージング市場の成長は、前臨床研究や医薬品開発に対する需要の高まり、マルチモーダル、ハイブリッド、AI主導型イメージングシステムの採用拡大、非侵襲的で高解像度のイメージング技術の進歩など、いくつかの要因によってもたらされます。コンパクトで持ち運びができ、使いやすいイメージングシステムの市場開拓は、学術研究機関、製薬会社、CROでの市場導入を促進しています。高感度、高特異性、リアルタイムのイメージングモダリティに対する需要の高まりは、多様な前臨床研究アプリケーションにおける市場の広がりをもたらしています。腫瘍学、神経学、循環器学、免疫学研究における小動物イメージングの利用の増加は、縦断的、定量的、トランスレーショナルイメージングソリューションの需要と相まって、市場成長の新たな機会を生み出しています。さらに、研究機関、製薬会社、イメージングソリューションプロバイダー間の協力関係の高まりや、革新的なイメージング技術の研究開発への投資の増加が、市場の拡大をさらに後押ししています。

調査対象企業の例（注目の42社）

  • Aspect Imaging Ltd.
  • Berthold Technologies GmbH & Co. KG
  • Bruker Corp.
  • LI-COR Biosciences, Inc.
  • Mediso Ltd.
  • MILabs B.V.
  • Miltenyi Biotec GmbH
  • New England Biolabs, Inc.
  • Northridge Tri-Modality Imaging, Inc.
  • PerkinElmer, Inc.
  • Scanco Medical AG
  • Sofie Biosciences, Inc.
  • Thermo Fisher Scientific Inc.
  • Uvp. LLC

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP14774

Global Small Animal Imaging (In-Vivo) Market to Reach US$4.8 Billion by 2030

The global market for Small Animal Imaging (In-Vivo) estimated at US$2.9 Billion in the year 2023, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Micro-Magnetic Resonance Imaging, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Optical Imaging segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$793.7 Million While China is Forecast to Grow at 7.0% CAGR

The Small Animal Imaging (In-Vivo) market in the U.S. is estimated at US$793.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$735.2 Million by the year 2030 trailing a CAGR of 7.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Small Animal Imaging (In-Vivo) Market - Key Trends and Drivers Summarized

Why Is Small Animal Imaging Essential for Preclinical Studies?

Small animal imaging (in-vivo) is crucial for preclinical studies as it provides non-invasive, high-resolution imaging solutions for monitoring biological processes in live animals. This technology is extensively used in drug development, cancer research, cardiovascular studies, and neuroscience to assess disease progression, therapeutic efficacy, and pharmacokinetics. Small animal imaging techniques, such as Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Computed Tomography (CT), offer real-time, longitudinal, and quantitative data, enhancing the reliability and translational value of preclinical research. The increasing focus on personalized medicine, targeted therapies, and molecular imaging is driving the adoption of small animal imaging systems across research institutions, pharmaceutical companies, and academic laboratories.

How Are Technological Advancements Enhancing Small Animal Imaging?

Technological advancements are enhancing small animal imaging by integrating multi-modal, hybrid, and AI-driven imaging systems that provide comprehensive insights into biological processes. The development of multi-modal imaging systems combining MRI, PET, SPECT, and CT modalities is enabling researchers to capture multiple data points simultaneously, improving the accuracy and depth of preclinical studies. Innovations in AI-based image analysis, deep learning algorithms, and data management systems are facilitating automated, high-throughput, and quantitative analysis of imaging data, reducing the time and complexity of preclinical workflows. Furthermore, the emergence of portable, compact, and user-friendly imaging systems is expanding the accessibility of advanced imaging technologies to small and mid-sized research labs, enhancing collaboration and knowledge sharing.

Which Market Segments Are Leading the Adoption of Small Animal Imaging?

Imaging modalities include micro-MRI, PET, SPECT, CT, optical imaging (bioluminescence and fluorescence), and ultrasound, with optical imaging and PET leading the market due to their high sensitivity, specificity, and real-time imaging capabilities. Use case encompass oncology, neurology, cardiology, infectious diseases, and immunology, with oncology being the largest segment due to the high prevalence of cancer research and drug development studies. End-users include academic and research institutions, pharmaceutical and biotechnology companies, and contract research organizations (CROs), with academic and research institutions being the primary adopters due to their focus on basic research and translational studies. Geographically, North America and Europe are the largest markets for small animal imaging due to advanced research infrastructure, while Asia-Pacific is emerging as a high-growth region driven by increasing investments in life sciences, expanding R&D activities, and growing focus on precision medicine.

What Are the Key Drivers of Growth in the Small Animal Imaging Market?

The growth in the small animal imaging market is driven by several factors, including the rising demand for preclinical research and drug development, increasing adoption of multi-modal, hybrid, and AI-driven imaging systems, and advancements in non-invasive, high-resolution imaging technologies. The development of compact, portable, and user-friendly imaging systems is driving market adoption among academic and research institutions, pharmaceutical companies, and CROs. The growing demand for high-sensitivity, high-specificity, and real-time imaging modalities is expanding the market reach among diverse preclinical research applications. The increasing use of small animal imaging in oncology, neurology, cardiology, and immunology research, coupled with the demand for longitudinal, quantitative, and translational imaging solutions, is creating new opportunities for market growth. Additionally, the rising collaborations between research institutes, pharmaceutical companies, and imaging solution providers and the increasing investments in R&D for innovative imaging technologies are further supporting market expansion.

Select Competitors (Total 42 Featured) -

  • Aspect Imaging Ltd.
  • Berthold Technologies GmbH & Co. KG
  • Bruker Corp.
  • LI-COR Biosciences, Inc.
  • Mediso Ltd.
  • MILabs B.V.
  • Miltenyi Biotec GmbH
  • New England Biolabs, Inc.
  • Northridge Tri-Modality Imaging, Inc.
  • PerkinElmer, Inc.
  • Scanco Medical AG
  • Sofie Biosciences, Inc.
  • Thermo Fisher Scientific Inc.
  • Uvp. LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Small Animal Imaging (In-Vivo) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Non-Invasive, High-Resolution Imaging Technologies Propel Market Innovation
    • Increasing Focus on Personalized Medicine and Molecular Imaging Expands Addressable Market Opportunity
    • Integration of Multi-Modal Imaging Systems (MRI, PET, SPECT, CT) Reinforces Market Competitiveness
    • Rising Investments in Oncology, Neurology, and Cardiovascular Research Spurs Market Adoption
    • Focus on Enhancing Imaging Sensitivity, Specificity, and Quantitative Analysis Drives Market Demand
    • Emergence of AI-Driven Image Analysis and Deep Learning Algorithms in Small Animal Imaging Accelerates Market Transformation
    • Growing Use of Fluorescence, Bioluminescence, and Ultrasound Imaging in In-Vivo Studies Sustains Market Growth
    • Development of Compact, User-Friendly, and High-Throughput Imaging Systems Expands Market Reach
    • Rising Preference for Longitudinal, Real-Time, and 4D Imaging Modalities Generates New Growth Opportunities
    • Growing Application of Small Animal Imaging in Infectious Diseases, Immunology, and Regenerative Medicine Spurs Market Expansion
    • Shift Towards Hybrid Imaging Platforms, Portable Solutions, and Remote Data Analysis Supports Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Small Animal Imaging (In-Vivo) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Small Animal Imaging (In-Vivo) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Small Animal Imaging (In-Vivo) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Micro-magnetic resonance imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Micro-magnetic resonance imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Micro-magnetic resonance imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Optical imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Optical imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Optical imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Nuclear imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Nuclear imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Nuclear imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Imaging Modalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Monitoring treatment response by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Monitoring treatment response by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Monitoring treatment response by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bio-distribution of drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Bio-distribution of drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Bio-distribution of drug by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cancer cell detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cancer cell detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Cancer cell detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Longitudinal studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Longitudinal studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Longitudinal studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
  • JAPAN
    • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
  • CHINA
    • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
  • EUROPE
    • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Small Animal Imaging (In-Vivo) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
  • FRANCE
    • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
  • GERMANY
    • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2014, 2024 & 2030

IV. COMPETITION